annual cash & cash equivalents:
$257.07M+$248.80M(+3009.94%)Summary
- As of today (August 3, 2025), CGON annual cash & cash equivalents is $257.07 million, with the most recent change of +$248.80 million (+3009.94%) on December 31, 2024.
- During the last 3 years, CGON annual cash & cash equivalents has risen by +$203.46 million (+379.54%).
- CGON annual cash & cash equivalents is now at all-time high.
Performance
CGON Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$41.47M-$215.60M(-83.87%)Summary
- As of today (August 3, 2025), CGON quarterly cash & cash equivalents is $41.47 million, with the most recent change of -$215.60 million (-83.87%) on March 31, 2025.
- Over the past year, CGON quarterly cash & cash equivalents has dropped by -$36.00 million (-46.47%).
- CGON quarterly cash & cash equivalents is now -83.87% below its all-time high of $257.07 million, reached on December 31, 2024.
Performance
CGON quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CGON Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3009.9% | -46.5% |
| 3 y3 years | +379.5% | -53.0% |
| 5 y5 years | +379.5% | -53.0% |
CGON Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +3009.9% | -83.9% | +401.7% |
| 5 y | 5-year | at high | +3009.9% | -83.9% | +401.7% |
| alltime | all time | at high | +3009.9% | -83.9% | +401.7% |
CGON Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $41.47M(-83.9%) |
| Dec 2024 | $257.07M(+3009.9%) | $257.07M(+492.2%) |
| Sep 2024 | - | $43.41M(+72.6%) |
| Jun 2024 | - | $25.16M(-67.5%) |
| Mar 2024 | - | $77.47M(+837.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $8.27M(-90.6%) | $8.27M(-19.5%) |
| Sep 2023 | - | $10.27M(-88.3%) |
| Dec 2022 | $88.14M(+64.4%) | - |
| Dec 2022 | - | $88.14M |
| Dec 2021 | $53.61M | - |
FAQ
- What is CG Oncology, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for CG Oncology, Inc.?
- What is CG Oncology, Inc. annual cash & cash equivalents year-on-year change?
- What is CG Oncology, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for CG Oncology, Inc.?
- What is CG Oncology, Inc. quarterly cash & cash equivalents year-on-year change?
What is CG Oncology, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of CGON is $257.07M
What is the all time high annual cash & cash equivalents for CG Oncology, Inc.?
CG Oncology, Inc. all-time high annual cash & cash equivalents is $257.07M
What is CG Oncology, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, CGON annual cash & cash equivalents has changed by +$248.80M (+3009.94%)
What is CG Oncology, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of CGON is $41.47M
What is the all time high quarterly cash & cash equivalents for CG Oncology, Inc.?
CG Oncology, Inc. all-time high quarterly cash & cash equivalents is $257.07M
What is CG Oncology, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, CGON quarterly cash & cash equivalents has changed by -$36.00M (-46.47%)